BV Science
BV Science is a US-based joint venture between Dr. Bata Ltd. (Hungary) and Vetanco S.A. (Argentina) that develops and distributes feed additives, mycotoxin inactivators, and oral vaccines for commercial poultry, swine, ruminant, and aquaculture producers, with global reach through its two parent companies' distribution networks across 40+ countries.
- Company typePrivate
- Founded2016
- HeadquartersLenexa, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BV Science does
BV Science is a privately held US-incorporated joint venture formed in 2016 between Hungary-based Dr. Bata Ltd. and Argentina-based Vetanco S.A., headquartered in Lenexa, Kansas, and operating as a unified R&D, marketing, and technical support business unit for animal nutrition and feed additives. The company develops and commercializes a portfolio of seven core products—Herbanoplex CP, Dysantic, Detoxa Plus, Gamaxine, Rumino Zyme, DI Heptarine S, and Uniwall MOS 25—plus the Biotech Vac oral subunit vaccine platform, targeting commercial poultry, swine, ruminant, and aquaculture producers with a focus on antibiotic-free production, gut health stabilization, mycotoxin inactivation, and metabolic disorder prevention. Underlying technology centers on proprietary enzymatic mycotoxin inactivation methods (patented by Dr. Arpad Bata), phytogenic compounds, prebiotic/probiotic fermentation products, and subunit vaccine constructs, with Vetanco contributing 30 years of biotech and intestinal health R&D (at ~8% of turnover) and Dr. Bata contributing 30+ years of enzymatic and phytotherapeutic expertise.
The business model is product-driven and distributed rather than service- or platform-based. Revenue flows through one-time feed additive and animal health product sales, with no disclosed pricing model or licensing terms. Distribution is exclusively channel-partner based: Vetanco handles the Americas (North, Central, and South America) and Dr. Bata handles the rest of the world, with a stated Dysantic footprint of more than 40 countries and "thousands of farmers" as end users. GTM motion combines channel-driven distribution with event-led demand generation (IPPE, CAHE, Latin American Poultry Congress, Animal Gut Health & Nutrition Summit, International Symposium on Alternatives to Antibiotics) and mid-funnel technical content marketing via scientific publications and conference papers. The company has no disclosed independent revenue or funding; growth is funded and operationally absorbed by its two parent companies, including a R$30M+ Dr. Bata factory build in Chapecó, Brazil announced in April 2022 as the first dedicated manufacturing site for the joint venture in South America.
BV Science firmographics
Firmographics- Name
- BV Science
- Legal name
- BV Science, Inc.
- Website
- https://bvscience.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BV Science is a US-based joint venture between Dr. Bata Ltd. (Hungary) and Vetanco S.A. (Argentina) that develops and distributes feed additives, mycotoxin inactivators, and oral vaccines for commercial poultry, swine, ruminant, and aquaculture producers, with global reach through its two parent companies' distribution networks across 40+ countries.
- Ownership category
- akta.pro rank
BV Science industry classification
Industry- Product category
- Animal Feed Additives
- NAICS
- Animal Food Manufacturing (31111), Animal Food Manufacturing (3111), Poultry and Poultry Product Merchant Wholesalers (42444)
- SIC
- Agricultural Prod-Livestock & Animal Specialties (200), Biological Products, (No Disgnostic Substances) (2836), Food And Kindred Products (2000)
- akta.pro primary industry
- Livestock & Poultry Nutrition (Feed & Premixes) (HLAMAHAD)
- akta.pro secondary industries
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Poultry & Avian Production Veterinary Services (HLAMABAC)
Keywords
Where BV Science is headquartered
LocationHeadquarters
- HQ city
- Lenexa
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
BV Science business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Revenue model
- Feed Additives Sales: BV Science generates revenue through the sale of feed additives and animal health products including Herbanoplex CP, Dysantic, Detoxa Plus, Gamaxine, Rumino Zyme, DI Heptarine S, and Uniwall MOS 25. Products are sold through distribution channels for poultry, swine, ruminants, and fish production.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
BV Science product offering
Product offeringCore offering
BV Science develops, manufactures, and commercializes feed additives and animal health products for poultry, swine, ruminant, and fish production. The portfolio includes phytocompounds, enzymatic mycotoxin inactivators, prebiotics, and vaccine technologies designed to enable antibiotic-free animal production. Products are developed jointly through the R&D capabilities of parent companies Dr. Bata Ltd. (Hungary) and Vetanco S.A. (Argentina), and distributed globally through these parent companies' channels.
Product overview
BV Science offers a portfolio of feed additives and animal health products developed through the joint efforts of Dr. Bata Ltd. and Vetanco S.A. The product line includes: Herbanoplex CP (phytocompound for poultry gut health), Dysantic (natural additive for swine), Detoxa Plus (mycotoxin inactivation for livestock), Gamaxine (immune-supporting prebiotic), Rumino Zyme (ruminant feed additive), DI Heptarine S (metabolic disorder treatment), and Uniwall MOS 25 (prebiotic for multiple species). These products are designed as key tools for antibiotic-free (ATB-free) production strategies in animal agriculture, addressing gut health, mycotoxin control, and metabolic disorders across poultry, swine, and ruminant species.
Differentiator
Problem solved
Functional benefit
Brands
- Herbanoplex CP: Phytocompound feed additive for preventing necrotic enteritis in poultry
- Dysantic
- Detoxa Plus
- Gamaxine
- Rumino Zyme
- DI Heptarine S
- Uniwall MOS 25
- Biotech Vac
Products and services
- Herbanoplex CP
Quantifiable outcome
- Detoxa Book reports mycotoxin analysis results from more than 40,000 feed and feedstuff samples across Latin America
- +1 more outcomes
Companies that use BV Science
Customer profileSegments4 records
Ideal customer profiles3 records
BV Science technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BV Science partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, flagship and minor.
- Vetanco BrazilcoreVetanco Brazil led the construction of Dr. Bata's first factory in Brazil in Chapecó/SC, located on the same site as the existing Vetanco Plant. The Chief Administrative Officer Daiane Cristina de Moura Müssnich oversaw the project with over 200 attendees at the foundation stone ceremony. The factory will produce eubiotics with R$30 million investment.
- Vetanco S.A.flagshipVetanco S.A. (Argentina) and Dr. Bata Ltd. (Hungary) formed the BV Science joint business unit in 2016. The partnership unifies R&D, marketing, and technical support to improve productivity and profitability of chemical-free animal production. Vetanco handles distribution for the Americas while Dr. Bata handles the rest of the world. Vetanco has invested nearly 8% of its turnover in R&D for 30 years, contributing biotech, intestinal health, and egg yolk immunoglobulin developments.
- Dr. Bata Ltd.flagshipDr. Bata Ltd. is a Hungarian-based biotech company committed to developing solutions for animal health for more than 30 years. Founded by Dr. Arpad Bata, a pioneer in enzymatic technologies for mycotoxin inactivation. Dr. Bata developed and holds patents for products related to biotechnological control of important animal production diseases. The company partnered with Vetanco to form BV Science, combining European and American R&D capabilities.
- BioinnovominorBioinnovo is a technology-based public-private company formed by INTA and Vetanco with focus on research and innovative development. Awarded the Balseiro Award 2017 for its contributions to the industry.
- Jefo Nutrition Inc.minorElizabeth Santin, Ph.D., Vice President of Research and Development at Jefo Nutrition Inc. co-led a workshop with Sherry Layton, BV Science's Chief Science Officer, at the 4th Animal Gut Health & Nutrition Summit on Precision Intestinal Nutrition.
Scale indicators6 records
Recent moves8 records
Expansion highlights5 records
BV Science competitors and assessment
Company assessmentBroad incumbents
- Elanco Animal Health: Large public animal health company offering pharmaceuticals, vaccines, and feed additives across poultry, swine, and ruminants. Overlaps with BV Science in gut health and poultry vaccines; competes from a much larger scale and capital base.
- dsm-firmenich Animal Nutrition & Health: Global leader in animal nutrition including vitamins, premixes, enzymes, and mycotoxin risk management. Direct overlap with BV Science's mycotoxin inactivation category via its Mycofix line.
- Evonik Animal Nutrition: Division of Evonik producing essential amino acids, probiotics, and feed additives for livestock and poultry. Comparable in gut health and nutrition technologies serving large feed mills globally.
- Kemin Industries: Private ingredient manufacturer providing feed additives, gut health, mycotoxin management, and animal nutrition solutions. Closely comparable product categories including mycotoxin control and gut health across species.
- Cargill Animal Nutrition: One of the largest global animal nutrition providers offering premixes, feed additives, and gut health solutions across poultry, swine, and ruminants. Comparable across feed additive and gut health categories.
- Phibro Animal Health: Diversified animal health and nutrition company with nutritional specialties and vaccines for poultry, swine, and cattle. Directly comparable in feed additive and vaccine adjacencies, with global commercial reach.
- Chr. Hansen (now Novonesis): Global bioscience company with major animal health and nutrition business in probiotics, enzymes, and silage inoculants. Direct overlap in probiotics/prebiotics and gut health additives for poultry and swine.
Direct peers
- Novus International: Global animal nutrition and feed additive company offering methionine, enzymes, and gut health solutions for poultry and livestock. Directly comparable as a feed-additive peer, and notably Chris Knight (BV Science consultant) previously served as Chief Innovation Officer at Novus.
- Jefo Nutrition: Specialty animal nutrition company focused on precision intestinal nutrition, prebiotics, and feed additives for poultry and swine. Directly comparable product overlap and a confirmed collaboration partner with BV Science at the Animal Gut Health & Nutrition Summit.
- Alltech: Private global animal nutrition company focused on gut health, mycotoxin management, and feed additives under the Alltech and Selko brands. Closely comparable in mycotoxin inactivation, prebiotics, and antibiotic-free production positioning.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
BV Science social profiles
Digital presenceBV Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
BV Science leadership team
Management profileNumber of profiles
Profiles6 records
BV Science subsidiaries and ownership
Company hierarchySubsidiaries1 record
BV Science funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BV Science M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BV Science
What does BV Science do?
BV Science develops, manufactures, and commercializes feed additives and animal health products for poultry, swine, ruminant, and fish production. The portfolio includes phytocompounds, enzymatic mycotoxin inactivators, prebiotics, and vaccine technologies designed to enable antibiotic-free animal production. Products are developed jointly through the R&D capabilities of parent companies Dr. Bata Ltd. (Hungary) and Vetanco S.A. (Argentina), and distributed globally through these parent companies' channels.
Is BV Science a public or private company?
BV Science is a private company. It is classified as corporate owned and is currently operating.
When was BV Science founded?
BV Science was founded in 2016. It employs 1 to 10 people.
Where is BV Science based?
BV Science is headquartered in Lenexa, United States, in the North America region.
How does BV Science make money?
One revenue line is on record: feed Additives Sales.
Who are BV Science's main competitors?
Broad incumbents on record are Elanco Animal Health, dsm-firmenich Animal Nutrition & Health, Evonik Animal Nutrition, Kemin Industries, Cargill Animal Nutrition, Phibro Animal Health and Chr. Hansen (now Novonesis). Direct peers are Novus International, Jefo Nutrition and Alltech.
Does BV Science have an API?
No public API is recorded for BV Science.
What industry is BV Science in?
BV Science's product category is Animal Feed Additives. Its primary akta.pro industry code is HLAMAHAD, Livestock & Poultry Nutrition (Feed & Premixes), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 31111 and its SIC code is 200.